Table 2 Comparison of CMR‐derived parameters among normal controls, NIDCM patients with and without T2DM

LV geometry and function

LVEDVi (mL/m²)

75.29 ± 15.05

163.15 (136.51, 200.08) ^*

160.58 (135.28, 202.25) ^*

LVESVi (mL/m²)

28.07 ± 8.20

126.64 (94.97, 159.57) ^*

128.83 (98.16, 163.34) ^*

LVSVi (mL/m²)

47.23 ± 9.81

37.81 (27.55, 48.25) ^*

34.30 ± 12.82 ^*,§

LVEF (%)

62.94 ± 6.65

22.79 (16.90, 30.32) ^*

21.75 ± 9.87 ^*

LVMI (g/m²)

42.73 ± 6.65

70.56 (59.95, 82.50) ^*

81.25 (61.57, 94.01) ^{*, §}

RVEF (%)

56.09 ± 7.06

32.30 (20.42, 46.77) ^*

27.12 (13.42, 41.11) ^{*, §}

LV remodelling index, g/mL

0.57 ± 0.11

0.42 (0.36, 0.50) ^*

0.46 (0.40, 0.57) ^{*, §}

Presence of LGE, n (%)

–

238 (70)

61 (66)

LV PS (%)

GRPS

34.00 (29.98, 40.93)

8.58 (5.91, 12.95) ^*

6.42 (4.66, 11.17) ^{*, §}

GCPS

 − 20.61 ± 2.60

 − 6.99 (− 9.45, − 5.32) ^*

 − 5.53 (− 8.14, 4.12) ^{*, §}

GLPS

 − 14.14 ± 2.22

 − 5.59 (− 7.34, − 4.23) ^*

 − 4.54 (− 5.89, − 3.22) ^{*, §}

LV PSSR (1/s)

Radial

2.10 (1.64, 2.54)

0.59 (0.43, 0.83) ^*

0.53 (0.36, 0.75) ^*

Circumferential

 − 1.07 (− 1.18, − 0.92)

 − 0.44 (− 0.56, − 0.33) ^*

 − 0.38 (− 0.50, − 0.30) ^{*, §}

Longitudinal

 − 0.79 (− 0.88, − 0.69)

 − 0.40 (− 0.52, − 0.31) ^*

 − 0.33 (− 0.47, − 0.26) ^{*, §}

LV PDSR (1/s)

Radial

 − 2.50 (− 3.10, − 2.00)

 − 0.61 (− 0.93, − 0.45) ^*

 − 0.56 (− 0.90, 0.38) ^*

Circumferential

1.26 ± 0.24

0.49 (0.36, 0.66) ^*

0.44 (0.31, 0.60) ^{*, §}

Longitudinal

0.91 ± 0.24

0.42 (0.33, 0.55) ^*

0.36 (0.26, 0.48) ^{*, §}